GlassScriptPhysician profile
Daniel R Harrington
NPI 1710365457
$12,338.62
in general payments reported to CMS, 2019-2025
15 companies · $4,302 in 2025
The $4,302 reported for 2025 was more than what 97% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $74.15 · 2021: $187 · 2022: $2,456 · 2023: $1,757 · 2024: $3,451 · 2025: $4,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,650 · Travel and Lodging: $2,363 · Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,650.00 |
| Travel and Lodging | $2,362.92 |
| Food and Beverage | $496.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $10,627.64 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $674.80 | 2023-2025 | Iovera |
| Ferring Pharmaceuticals INC. | $328.28 | 2019-2025 | Euflexxa |
| Bioventus LLC | $229.46 | 2019-2025 | Xcell, Durolane |
| Sanofi-Aventis U.S. LLC | $85.04 | 2021-2022 | |
| Dynasplint Systems INC. | $73.55 | 2022 | |
| Molnlycke Health Care US, LLC | $67.78 | 2025 | Mepilex Border Sacrum, Mepilex Border Post-Op Ag, Mlnlycke Z-Flex Fluidized Heel Boot |
| Endo Pharmaceuticals INC. | $58.53 | 2019-2022 | |
| Depuy Synthes Sales INC. | $46.28 | 2020-2025 | Monovisc, Orthovisc |
| Zimmer Biomet Holdings, INC. | $40.66 | 2022 | |
| Djo, LLC | $35.29 | 2019 | |
| Boston Scientific Corporation | $21.91 | 2021 | |
| Pacira Therapeutics, INC. | $18.79 | 2019 | |
| Tenex Health INC. | $15.81 | 2021 | |
| Smith+Nephew, INC. | $14.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Harrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.